120 related articles for article (PubMed ID: 21358690)
21. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program.
Kato K; Kanda Y; Eto T; Muta T; Gondo H; Taniguchi S; Shibuya T; Utsunomiya A; Kawase T; Kato S; Morishima Y; Kodera Y; Harada M;
Biol Blood Marrow Transplant; 2007 Jan; 13(1):90-9. PubMed ID: 17222757
[TBL] [Abstract][Full Text] [Related]
22. Oral malignancies following HSCT: graft versus host disease and other risk factors.
Demarosi F; Lodi G; Carrassi A; Soligo D; Sardella A
Oral Oncol; 2005 Oct; 41(9):865-77. PubMed ID: 16084755
[TBL] [Abstract][Full Text] [Related]
23. Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method.
Gutiérrez-Aguirre CH; Ruiz-Argüelles G; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; García-Rodríguez F; López-Otero A; Herrera-Garza JL; Gómez-Almaguer D
Ann Hematol; 2010 Oct; 89(10):1045-52. PubMed ID: 20490794
[TBL] [Abstract][Full Text] [Related]
24. High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.
Forrest DL; Hogge DE; Nevill TJ; Nantel SH; Barnett MJ; Shepherd JD; Sutherland HJ; Toze CL; Smith CA; Lavoie JC; Song KW; Voss NJ; Gascoyne RD; Connors JM
J Clin Oncol; 2005 Nov; 23(31):7994-8002. PubMed ID: 16204014
[TBL] [Abstract][Full Text] [Related]
25. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
[TBL] [Abstract][Full Text] [Related]
26. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
27. [Second transplantation for graft failure after allogeneic hematopoietic stem cell transplantation--a retrospective survey by Kanto Study Group for Cell Therapy].
Hagihara M; Kanamori H; Sakai M; Mori T; Nakaseko C; Aotsuka N; Uehara T; Sakura T; Yoshiba F; Kawai N; Tanaka M; Fujisawa S; Ohwada C; Wakita H; Yokota A; Kawamura T; Maruta A; Sakamaki H; Okamoto S;
Rinsho Ketsueki; 2010 Jun; 51(6):390-7. PubMed ID: 20622484
[TBL] [Abstract][Full Text] [Related]
28. Secondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA-87 and LALA-94 trials.
Tavernier E; Le QH; de Botton S; Dhédin N; Bulabois CE; Reman O; Vey N; Lhéritier V; Dombret H; Thomas X
Cancer; 2007 Dec; 110(12):2747-55. PubMed ID: 17963265
[TBL] [Abstract][Full Text] [Related]
29. [Allogeneic hematopoietic stem cell transplantation for acute lymphocytic leukemia].
Chen H; Ren HY; Guo NL; Huang XJ; Liu KY; Xu LP; Zhang YC; Zheng H; Wu T; Liu DH; Yang SM; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):87-90. PubMed ID: 14990046
[TBL] [Abstract][Full Text] [Related]
30. [Therapeutic efficacy of hematopoietic stem cell transplantation in patients with chronic myelogenous leukemia].
Liu QF; Fan ZP; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1227-9, 1241. PubMed ID: 15567763
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients.
Sanz J; Arriaga F; Montesinos P; Ortí G; Lorenzo I; Cantero S; Puig N; Moscardó F; de la Rubia J; Sanz G; Sanz MA
Bone Marrow Transplant; 2007 May; 39(9):555-61. PubMed ID: 17351645
[TBL] [Abstract][Full Text] [Related]
32. High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation. The Spanish Group of Allo-PBPCT.
Urbano-Ispizua A; García-Conde J; Brunet S; Hernández F; Sanz G; Petit J; Bargay J; Figuera A; Rovira M; Solano C; Ojeda E; de la Rubia J; Rozman C
Haematologica; 1997; 82(6):683-9. PubMed ID: 9499667
[TBL] [Abstract][Full Text] [Related]
33. [Hyperacute graft versus host disease after allo-stem cell transplantation, analysis of 118 cases].
Huang X; Chen Y; Guo N; Ren H; Zhang Y; Xu L; Gao Z; Lu D
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):511-4. PubMed ID: 12133493
[TBL] [Abstract][Full Text] [Related]
34. Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation.
Kersting S; Hené RJ; Koomans HA; Verdonck LF
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1169-75. PubMed ID: 17889353
[TBL] [Abstract][Full Text] [Related]
35. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
[TBL] [Abstract][Full Text] [Related]
36. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
[TBL] [Abstract][Full Text] [Related]
37. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms.
Murashige N; Kami M; Kishi Y; Kim SW; Takeuchi M; Matsue K; Kanda Y; Hirokawa M; Kawabata Y; Matsumura T; Kusumi E; Hirabayashi N; Nagafuji K; Suzuki R; Takeuchi K; Oshimi K
Br J Haematol; 2005 Aug; 130(4):561-7. PubMed ID: 16098071
[TBL] [Abstract][Full Text] [Related]
39. A retrospective review of the outcome after second or subsequent allogeneic transplantation.
Kedmi M; Resnick IB; Dray L; Aker M; Samuel S; Gesundheit B; Slavin S; Or R; Shapira MY
Biol Blood Marrow Transplant; 2009 Apr; 15(4):483-9. PubMed ID: 19285636
[TBL] [Abstract][Full Text] [Related]
40. Allogeneic stem cell transplantation: low immunoglobulin levels associated with decreased survival.
Norlin AC; Sairafi D; Mattsson J; Ljungman P; Ringdén O; Remberger M
Bone Marrow Transplant; 2008 Feb; 41(3):267-73. PubMed ID: 17994123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]